19 General Introduction 1 48. Woerle, H. J. et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Diabetes Research and Clinical Practice 77, 280–285 (2007). 49. Dodd, L. E. et al. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clinical Trials (London, England) 17, 472–482 (2020). 50. Aflaki, K., Vigod, S. & Ray, J. G. Part I: A friendly introduction to latent class analysis. Journal of Clinical Epidemiology 147, 168–170 (2022). 51. Mori, M., Krumholz, H. M. & Allore, H. G. Using Latent Class Analysis to Identify Hidden Clinical Phenotypes. JAMA 324, 700 (2020). 52. Calfee, C. S. et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. The Lancet. Respiratory Medicine 2, 611–620 (2014). 53. Calfee, C. S. et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. The Lancet Respiratory Medicine 6, 691–698 (2018).
RkJQdWJsaXNoZXIy MTk4NDMw